Literature DB >> 219700

Pathogenesis of reactivated latent murine cytomegalovirus infection.

J D Shanley, M C Jordan, M L Cook, J G Stevens.   

Abstract

Sixteen weeks after inoculation, murine cytomegalovirus (MCMV) can no longer be detected in the tissues of mice. However, a 2-week course of immunosuppression with antilymphocyte serum and cortisone acetate results in reactivation and dissemination of the latent virus in all animals. In this study of reactivation, MCMV was first detected in the liver, usually during the first week of immunosuppression, and virus replication was shown to be restricted to hepatocytes. Subsequently, a viremia occurred, with spread of infection to other organs. The highest titers of virus were reached in salivary glands in which replication occurred in serous acinar cells. In the lung, virus-specific abnormalities were difficult to detect because of superimposed bacterial and fungal infections. However, interstitial pneumonitis could be produced when cortisone acetate was deleted from the immunosuppressive regimen. Although the site of virus latency has not been defined, this model system will be useful for study of reactivation of latent cytomegalovirus infection.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 219700      PMCID: PMC2042281     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  17 in total

1.  CYTOMEGALIC INCLUSION DISEASE IN PATIENTS WITH ACUTE LEUKEMIA.

Authors:  G P BODEY; P T WERTLAKE; G DOUGLAS; R H LEVIN
Journal:  Ann Intern Med       Date:  1965-05       Impact factor: 25.391

2.  Mouse salivary gland virus infections.

Authors:  A MANNINI; D N MEDEARIS
Journal:  Am J Hyg       Date:  1961-05

3.  Chronic subclinical infection with mouse salivary gland virus.

Authors:  I BRODSKY; W P ROWE
Journal:  Proc Soc Exp Biol Med       Date:  1958-12

4.  Reactivation of murine cytomegalovirus by cyclophosphamide.

Authors:  D R Mayo; J A Armstrong; M Ho
Journal:  Nature       Date:  1977-06-23       Impact factor: 49.962

5.  Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice.

Authors:  A R Brody; J E Craighead
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

6.  Cytomegalovirus infections during acute childhood leukemia.

Authors:  D Henson; S E Siegel; D A Fuccillo; E Matthew; A S Levine
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

7.  Cytomegalovirus infections in organ transplantation and post transfusion. An hypothesis.

Authors:  D J Lang
Journal:  Arch Gesamte Virusforsch       Date:  1972

8.  Induction of disseminated virulent cytomegalovirus infection by immunosuppression of naturally chronically infected wild mice.

Authors:  M B Gardner; J E Officer; J Parker; J D Estes; R W Rongey
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

Review 9.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

10.  Role of macrophages in resistance to murine cytomegalovirus.

Authors:  M K Selgrade; J E Osborn
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  20 in total

Review 1.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

2.  DMSO induces reactivation of cytomegalovirus in vitro from spleens of latently infected mice. Brief report.

Authors:  S Blackett; A Gupta; C A Mims
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis.

Authors:  Harald Krenzlin; Prajna Behera; Viola Lorenz; Carmela Passaro; Mykola Zdioruk; Michal O Nowicki; Korneel Grauwet; Hong Zhang; Magdalena Skubal; Hirotaka Ito; Rachel Zane; Michael Gutknecht; Marion B Griessl; Franz Ricklefs; Lai Ding; Sharon Peled; Arun Rooj; C David James; Charles S Cobbs; Charles H Cook; E Antonio Chiocca; Sean E Lawler
Journal:  J Clin Invest       Date:  2019-03-11       Impact factor: 14.808

4.  Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice.

Authors:  R H Rubin; P Lynch; M S Pasternack; D Schoenfeld; D N Medearis
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

5.  Immunosuppression induces transcription of murine cytomegalovirus glycoprotein H in the eye and at non-ocular sites.

Authors:  Y Duan; S S Atherton
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Isolation of a cytomegalovirus-like agent from wild rats.

Authors:  C A Bruggeman; H Meijer; P H Dormans; W M Debie; G E Grauls; C P van Boven
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Replication of murine cytomegalovirus in lung macrophages: effect of phagocytosis of bacteria.

Authors:  J D Shanley; E L Pesanti
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

8.  Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells.

Authors:  Dai Wang; Qian-Chun Yu; Jörg Schröer; Eain Murphy; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-05       Impact factor: 11.205

9.  Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus.

Authors:  M C Jordan; V L Mar
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

10.  Effects of antiviral agents on murine cytomegalovirus-induced macrophage dysfunction.

Authors:  J D Shanley; E L Pesanti
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.